Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
pharmacology, toxicology and pharmaceutics
Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice
Toxicology, Volume 274, No. 1-3, Year 2010
Notification
URL copied to clipboard!
Description
The nephroprotective effect of coenzyme Q10 was investigated in mice with acute renal injury induced by a single i.p. injection of cisplatin (5. mg/kg). Coenzyme Q10 treatment (10. mg/kg/day, i.p.) was applied for 6 consecutive days, starting 1 day before cisplatin administration. Coenzyme Q10 significantly reduced blood urea nitrogen and serum creatinine levels which were increased by cisplatin. Coenzyme Q10 significantly compensated deficits in the antioxidant defense mechanisms (reduced glutathione level and superoxide dismutase activity), suppressed lipid peroxidation, decreased the elevations of tumor necrosis factor-α, nitric oxide and platinum ion concentration, and attenuated the reductions of selenium and zinc ions in renal tissue resulted from cisplatin administration. Also, histopathological renal tissue damage mediated by cisplatin was ameliorated by coenzyme Q10 treatment. Immunohistochemical analysis revealed that coenzyme Q10 significantly decreased the cisplatin-induced overexpression of inducible nitric oxide synthase, nuclear factor-κB, caspase-3 and p53 in renal tissue. It was concluded that coenzyme Q10 represents a potential therapeutic option to protect against acute cisplatin nephrotoxicity commonly encountered in clinical practice. © 2010 Elsevier Ireland Ltd.
Authors & Co-Authors
Fouad, Amr A.
Saudi Arabia, Al-ahsa
King Faisal University
al-Sultan, Ali Ibrahim
Saudi Arabia, Al-ahsa
King Faisal University
Refaie, Shereen Mahmoud
Saudi Arabia, Al-ahsa
King Faisal University
Yacoubi, Mohamed Tahar
Saudi Arabia, Al-ahsa
King Faisal University
Statistics
Citations: 79
Authors: 4
Affiliations: 1
Identifiers
Doi:
10.1016/j.tox.2010.05.007
ISSN:
0300483X
Research Areas
Cancer
Violence And Injury